Coincidentally, FebriDx will have it's 10th birthday at that time. Like most ten year olds, it also hasn't generated revenue and has been scolded by the authorities.
From the Cash Flow Report issued yesterday:
1) "Lumos recorded unaudited revenue of $2.0 million for the quarter...."
2) "Lumos generated $1.9 million from the provision of diagnostic test development services and contract
manufacturing during the March quarter...."
3) "Orders for FebriDx from distributors in four European markets remained relatively modest but are
starting to gain momentum."
4) "ViraDx is currently under review by the US FDA for Emergency Use Authorization (EUA)."
and 5) "Cash usage for the quarter of $3.2 million, average of $1.1 million per month"
Why is there talk of either product turning this company around? $2MM - $1.9MM = $100,000 over 3 months. At best FebriDx is generating $34k a month and their burn is 32x that!
Can someone tell me why they are wasting OUR investments on regulatory expenses when other companies are discontinuing their covid related products and there are multiple covid/flu products already on the market?
- Forums
- ASX - By Stock
- LDX
- Ann: Change in substantial holding
Ann: Change in substantial holding, page-5
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LDX (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.8¢ |
Change
0.004(9.09%) |
Mkt cap ! $35.79M |
Open | High | Low | Value | Volume |
4.6¢ | 4.8¢ | 4.5¢ | $116.2K | 2.494M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 381500 | 4.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.8¢ | 168426 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 381500 | 0.045 |
3 | 370000 | 0.044 |
5 | 1097085 | 0.043 |
6 | 299994 | 0.042 |
2 | 279025 | 0.041 |
Price($) | Vol. | No. |
---|---|---|
0.048 | 168426 | 4 |
0.049 | 190851 | 3 |
0.050 | 533000 | 3 |
0.052 | 211000 | 2 |
0.054 | 18000 | 1 |
Last trade - 16.10pm 15/10/2024 (20 minute delay) ? |
Featured News
LDX (ASX) Chart |
The Watchlist
JBY
JAMES BAY MINERALS LIMITED
Andrew Dornan, Executive Director
Andrew Dornan
Executive Director
SPONSORED BY The Market Online